Generex Biotechnology Announces That It Has Produced MetControl, the Company's Proprietary Metformin Chewing Gum Product for Upcoming Clinical Study
May 12, 2008 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 12, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced...
Generex Study Proposes Increased Reporting of Clinical Outcomes to Support Reimbursement of Non-Injectable Insulin Options
May 07, 2008 08:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 7, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced...
Generex Biotechnology Announces North American Initiation of Generex Oral-lyn Phase III Diabetes Study
April 07, 2008 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 7, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced...
Generex Biotechnology and SciGen, Ltd. Enter Into Distribution Agreement for Generex Oral-lyn in China
April 01, 2008 10:12 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 1, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and...
Generex Biotechnology Raises $20,650,000 Through Private Placement
April 01, 2008 07:38 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 1, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today that it has signed definitive agreements for the issuance of 8% Secured Convertible...
Generex Biotechnology Receives Indian Purchase Order for Generex Oral-lyn
March 25, 2008 10:20 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 25, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth,...
Generex Biotechnology Clarifies Stance of Medical Affairs VP
March 20, 2008 11:51 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 20, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today...
Generex Biotechnology Announces That Its Protocol for Metcontrol, the Company's Proprietary Metformin Chewing Gum Product, Will Be Submitted to Regulatory Agencies for the Conduct of a Clinical Study
March 12, 2008 12:47 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 12, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth,...
Generex Biotechnology Announces That Supplies for a Phase III Study of Generex Oral-lyn for a Number of Clinical Sites Have Been Packaged and are Ready for Shipping
March 11, 2008 12:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 11, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth,...
Generex Biotechnology Comments On Recent Trading Activity
March 10, 2008 15:55 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 10, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth,...